Search research articles
Contact Us
Filters
Showing results (71-80 of 95) with videos related to
Page
of 10
Sort By:
Cancer Discovery
|
October 28, 2016
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
Jennifer L Bishop, Daksh Thaper, Sepideh Vahid, et al.
Advanced Healthcare Materials
|
February 16, 2025
3D Bioprinted Coaxial Testis Model Using Human Induced Pluripotent Stem Cells:A Step Toward Bicompartmental Cytoarchitecture and Functionalization
Meghan A Robinson, Sonia Hy Kung, Khaled Ym Youssef, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2015
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
Arun A Azad, Stanislav V Volik, Alexander W Wyatt, et al.
Biorxiv : the Preprint Server for Biology
|
May 15, 2024
Deciphering the Transcription Factor Landscape in Neuroendocrine Prostate Cancer Progression: A Novel Approach to Understand NE Transdifferentiation
Yu Wang, Hui Xue, Xiaohui Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 17, 2025
Deciphering the Transcription Factor Landscape in Prostate Cancer Progression: A Novel Approach to Understand NE Transdifferentiation
Yu Wang, Hui Xue, Xiaohui Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2018
Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer
Amilcar Flores-Morales, Tobias B Bergmann, Charlotte Lavallee, et al.
Cancer Research
|
January 14, 2021
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability
Raunak Shrestha, Marta Llaurado Fernandez, Amy Dawson, et al.
Cancer Discovery
|
June 26, 2012
The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression
Laurie E Littlepage, Adam S Adler, Hosein Kouros-Mehr, et al.
Gynecologic Oncology
|
August 9, 2023
Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma
Nelson K Y Wong, Marta Llaurado Fernandez, Felix K F Kommoss, et al.
Cancer Research
|
December 21, 2013
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development
Dong Lin, Alexander W Wyatt, Hui Xue, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 95) with videos related to
Sort By:
Page
of 10
Cancer Discovery
|
October 28, 2016
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
Jennifer L Bishop, Daksh Thaper, Sepideh Vahid, et al.
Advanced Healthcare Materials
|
February 16, 2025
3D Bioprinted Coaxial Testis Model Using Human Induced Pluripotent Stem Cells:A Step Toward Bicompartmental Cytoarchitecture and Functionalization
Meghan A Robinson, Sonia Hy Kung, Khaled Ym Youssef, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2015
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
Arun A Azad, Stanislav V Volik, Alexander W Wyatt, et al.
Biorxiv : the Preprint Server for Biology
|
May 15, 2024
Deciphering the Transcription Factor Landscape in Neuroendocrine Prostate Cancer Progression: A Novel Approach to Understand NE Transdifferentiation
Yu Wang, Hui Xue, Xiaohui Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 17, 2025
Deciphering the Transcription Factor Landscape in Prostate Cancer Progression: A Novel Approach to Understand NE Transdifferentiation
Yu Wang, Hui Xue, Xiaohui Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2018
Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer
Amilcar Flores-Morales, Tobias B Bergmann, Charlotte Lavallee, et al.
Cancer Research
|
January 14, 2021
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability
Raunak Shrestha, Marta Llaurado Fernandez, Amy Dawson, et al.
Cancer Discovery
|
June 26, 2012
The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression
Laurie E Littlepage, Adam S Adler, Hosein Kouros-Mehr, et al.
Gynecologic Oncology
|
August 9, 2023
Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma
Nelson K Y Wong, Marta Llaurado Fernandez, Felix K F Kommoss, et al.
Cancer Research
|
December 21, 2013
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development
Dong Lin, Alexander W Wyatt, Hui Xue, et al.
Page
of 10